Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

The therapeutic options available for patients with multiple myeloma have greatly expanded over the past decade and incorporating these novel agents into routine clinical practice has significantly improved outcomes. The next generation of therapeutics is available for relapsed and refractory patien...

Full description

Bibliographic Details
Main Authors:	Mary Steinbach, Kelley Julian, Brian McClune, Douglas W. Sborov
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-07-01
Series:	Therapeutic Advances in Hematology
Online Access:	https://doi.org/10.1177/20406207221100659

Similar Items

Hospitalization at the end of life in patients with multiple myeloma
by: Saqib Abbasi, et al.
Published: (2021-03-01)

PIKing the next therapeutic target in multiple myeloma
by: Jessica L. Caro, et al.
Published: (2020-06-01)

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
by: Kellen Gil, et al.
Published: (2022-05-01)

Financial toxicity in hematological malignancies: a systematic review
by: Evguenia Ouchveridze, et al.
Published: (2022-04-01)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
by: Ciara Tierney, et al.
Published: (2021-06-01)

Long term responders in frontline multiple myeloma—exception vs expectation of the modern era
by: Muhamed Baljevic, et al.
Published: (2024-07-01)

Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics.
by: Ella Willenbacher, et al.
Published: (2016-01-01)

Engineering orthogonal signaling pathways to probe sequence space capacity
by: McClune, Conor James.
Published: (2020)

A Medical Home for Children with Special Health Care Needs in Rural Locations
by: Amy J McClune
Published: (2012-03-01)

Joining the dots: reconstructing 3D environments and movement paths using animal-borne devices
by: David W. McClune
Published: (2018-05-01)

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
by: Qiumei Yao, et al.
Published: (2019-06-01)

Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
by: Niccolo Bolli, et al.
Published: (2020-02-01)

Next Generation Therapeutics for the Treatment of Myelofibrosis
by: Douglas Tremblay, et al.
Published: (2021-04-01)

Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma
by: Xiaojia Zuo, et al.
Published: (2022-12-01)

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
by: Anna Oberle, et al.
Published: (2017-06-01)

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
by: Aleksander Salomon-Perzyński, et al.
Published: (2022-07-01)

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma
by: Mo Zhou, et al.
Published: (2024-03-01)

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
by: Nicole Balmaceda, et al.
Published: (2021-06-01)

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
by: Paola Pacelli, et al.
Published: (2022-11-01)

Constraints on the expansion of paralogous protein families
by: McClune, Conor James, et al.
Published: (2021)

Developing scientific literacy : using news media in the classroom /
by: 426790 Jarman, Ruth, et al.
Published: (2007)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma
by: Francesca Scionti, et al.
Published: (2023-03-01)

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
by: Andrew D. Trunk, et al.
Published: (2023-01-01)

Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
by: Shengnan Yu, et al.
Published: (2019-08-01)

Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma
by: Ikbal Atli E, et al.
Published: (2021-03-01)

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
by: Valeria Ferla, et al.
Published: (2022-08-01)

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing.
by: Miyoung Kim, et al.
Published: (2021-01-01)

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
by: Denisa Weiser Drozdkova, et al.
Published: (2021-06-01)

Antibody-drug conjugate therapies in multiple myeloma—what’s next on the horizon?
by: Monique Hartley-Brown, et al.
Published: (2022-01-01)

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma
by: Kevin Miller, et al.
Published: (2024-05-01)

What is the next generation therapeutic strategy for castration-resistant prostate cancer
by: Si-Meng Wen, et al.
Published: (2015-04-01)

Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
by: Hong Phuong Nguyen, et al.
Published: (2023-08-01)

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
by: Angélique Bruyer, et al.
Published: (2023-12-01)

Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies
by: Alessandro Allegra, et al.
Published: (2021-10-01)

Next generation therapeutics for Alzheimer's disease
by: Dale E. Bredesen, et al.
Published: (2013-05-01)

Bioengineering of Extracellular Vesicles: Exosome-Based Next-Generation Therapeutic Strategy in Cancer
by: Priyanka Saha, et al.
Published: (2021-10-01)

Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2022-12-01)

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
by: Anna Minchom, et al.
Published: (2018-07-01)

Different evasion strategies in multiple myeloma
by: Chaofan Wang, et al.
Published: (2024-02-01)